Roivant Sciences G&A decreased by 9.6% to $158.25M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.6%, from $147.09M to $158.25M. Over 3 years (FY 2021 to FY 2025), G&A shows a downward trend with a -7.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Rising G&A as a percentage of revenue may indicate organizational bloat, while stability suggests effective cost management.
Detailed definition
General and administrative expenses cover the overhead costs of running the business, including executive salaries, lega...
Peer comparison
Standard operating expense category; used to assess administrative leverage.
Metric ID:
general_and_administrativeHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.75M | $437.78M | $115.53M | $138.97M | $149.07M | $91.28M | $88.58M | $128.17M | $108.10M | $99.89M | $202.88M | $141.55M | $147.09M | $134.02M | $143.13M | $175.07M | $158.25M |
| QoQ Change | — | +429.0% | -73.6% | +20.3% | +7.3% | -38.8% | -3.0% | +44.7% | -15.7% | -7.6% | +103.1% | -30.2% | +3.9% | -8.9% | +6.8% | +22.3% | -9.6% |
| YoY Change | — | — | — | — | +80.1% | -38.8% | — | — | — | +9.4% | +129.0% | +10.4% | +36.1% | +34.2% | -29.5% | +23.7% | +7.6% |
Range$82.75M – $437.78M
CAGR+17.6%
Avg YoY Growth+26.2%
Median YoY Growth+17.1%
Business Segments
| Segment | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|
| Reportable Segment | $37.95M | $59.95M | $49.19M |
| Total | $143.13M | $175.07M | $158.25M |
G&A at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's g&a?
- Roivant Sciences (ROIV) reported g&a of $158.25M in Q1 2026.
- How has Roivant Sciences's g&a changed year-over-year?
- Roivant Sciences's g&a increased by 7.6% year-over-year, from $147.09M to $158.25M.
- What is the long-term trend for Roivant Sciences's g&a?
- Over 3 years (2021 to 2025), Roivant Sciences's g&a has grown at a -7.6% compound annual growth rate (CAGR), from $775.03M to $610.47M.
- What does g&a mean?
- The overhead costs required to manage and support the company's operations.